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Abstract
Differentiated cells from human embryonic stem cells (hESCs) provide an unlimited source of cells for use in regenerative
medicine. The recent derivation of human induced pluripotent cells (hiPSCs) provides a potential supply of pluripotent cells
that avoid immune rejection and could provide patient-tailored therapy. In addition, the use of pluripotent cells for drug
screening could enable routine toxicity testing and evaluation of underlying disease mechanisms. However, prior to
establishment of patient specific cells for cell therapy it is important to understand the basic regulation of cell fate decisions
in hESCs. One critical issue that hinders the use of these cells is the fact that hESCs survive poorly upon dissociation, which
limits genetic manipulation because of poor cloning efficiency of individual hESCs, and hampers production of large-scale
culture of hESCs. To address the problems associated with poor growth in culture and our lack of understanding of what
regulates hESC signaling, we successfully developed a screening platform that allows for large scale screening for small
molecules that regulate survival. In this work we developed the first large scale platform for hESC screening using laser
scanning cytometry and were able to validate this platform by identifying the pro-survival molecule HA-1077. These small
molecules provide targets for both improving our basic understanding of hESC survival as well as a tool to improve our
ability to expand and genetically manipulate hESCs for use in regenerative applications.
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Introduction
Human embryonic stem cells (hESCs) are derived from the
developing blastocyst and have the potential to differentiate into
all cell types in the body [1]. This pluripotent characteristic gives
these cells enormous potential for both therapeutic uses and as a
potent tool to study development in vitro. Development of
applications for hESCs has been hampered by heterogeneity
within stem cell cultures as well as variance in differentiation
potential [2,3]. One source of this variation is introduced by
culture methodology: hESCs are typically passaged as clumps of
cells due to poor survival as single cells [4]. This poor survival of
individual hESCs increases the difficulty of manipulating these
cells, which hampers the ability to clonally expand a cell line
containing a desired modification from one integration event. One
method of improving survival of hESCs is through the manipu-
lation of proteins regulating apoptosis and the cell cycle. It has
recently been shown that high levels of the protein Rem2 improve
hESC survival by regulating Cyclin D1 and p53 to control the cell
cycle and apoptosis of hESCs [5]. In addition, expression of anti-
apoptotic proteins such as Bcl2 [6] or Bcl-XL [7] has been shown
to improve the survival of single hESCs without altering their self-
renewal or differentiation potential, however overexpression of
oncogenes as a method of improving hESC survival would limit
the therapeutic potential of the modified hESCs. A more transient
method of improving hESC survival is through addition of growth
factors or other small molecules to the culture medium [4,8,9]. It is
now known that small molecule-mediated inhibition of Rho-
associated protein kinase (ROCK) improves the survival of
dissociated single hESCs [10], a result we confirmed using a
novel high content screening assay [11]. ROCK inhibitors are also
used to promote survival of hESCs during recovery from
cryopreservation [12,13,14]. However, even treatment with
ROCK inhibitors only results in a modest improvement in clonal
efficiency of dissociated hESCs [15].
In our previous work, we identified a ROCK inhibitor, HA-
1077, as promoting the survival of dissociated hESCs using a high
content screening assay to test a small set of approximately 1600
compounds [11]. Other groups have also performed high content
screening (HCS) assays using hESCs and have consistently
identified multiple small molecules that promote hESC survival
by inhibiting ROCK [15,16,17]. These screens, and our initial
high content screen, all focused on small compound libraries or
libraries composed primarily of characterized compounds and
drugs with known targets. While screening well-characterized
compounds can be helpful in understanding the mechanism of hits
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obtained, the commonly used libraries of well-characterized
compounds, Biomol and Prestwick, have now been independently
screened on hESCs by multiple labs, and all have identified only
compounds that inhibit ROCK at various efficacies. In order to
search for novel compounds that may regulate hESC survival by
affecting non-ROCK pathways or to discover ROCK inhibitors
with greater efficacies, we set out to screen the larger, more diverse
libraries available at the UCLA Molecular Screening Shared
Resource (MSSR).
In the work presented here we describe steps taken to optimize
our previously published high content screening assay for use in
screening large compound libraries. These optimizations include
decreasing the length of the assay to more specifically target
survival and changing the plate setup to a feeder-free culture
system to reduce variation. In addition we have tested various
DNA and viability dyes in order to replace the requirement for
immunostaining in our previous screening assay, which is labor
intensive and expensive. In total we evaluated three different
readouts for survival using the Acumen laser cytometer, including
live cell analysis of OCT4-EGFP using a reporter hESC line; use
of the cell viability dye propidium iodide; and finally the cell
viability dye Calcein AM. Using this optimized assay we screened
,85,000 compounds for their effects on hESC survival. In order
to distinguish surviving hESCs from background and non-specific
signal, we developed a set of filtering parameters to use in
quantifying surviving cells. The small molecule that produced the
greatest improvement in hESC survival was confirmed to be a
ROCK inhibitor, reinforcing the feasibility of this novel screening
platform. Additional targets were found and although they were
not as efficient at promoting survival as the ROCK inhibitor, they
may prove useful in combination approaches to increase survival
and increase our understanding of how survival is regulated in
hESCs. In summary, in this work we have developed a novel
screening platform using laser cytometry for use with hESCs
without the need for fixation or extensive time or cost constraints.
This optimized screening platform, which now enables large scale
screening analysis of surviving hESCs after dissociation, could be
used in further chemical screens, or in complementary DNA
(cDNA) or RNA inhibtion (RNAi) based high throughput screens.
Further this dataset provides a more comprehensive evaluation of
chemical space for modifiers of survival in hESCs.
Materials and Methods
Cell Preparation for High Throughput Screening
hESCs (H1 OCT4-GFP [13] and H9 (WiCell) lines, passage
51–73) cultured under standard conditions [18] on mitomycin C-
inactivated CF1 mouse embryonic fibroblasts (MEFs) were
dissociated to single cells using 0.05% trypsin-EDTA (Life
Technologies). After incubating 5 minutes in trypsin at 37uC, an
equal volume of trypsin inhibitor (Life Technologies) was added.
Cells were passed through a 40 mm mesh filter (BD Biosciences)
and centrifuged at 1,000 rpm (2006g) for 5 minutes. After
centrifugation cells were resuspended in 5 ml MEF conditioned
medium (CM) and an aliquot was taken for live cell quantification
using trypan blue exclusion. hESCs were then diluted to the
desired concentration immediately prior to addition to screening
plates.
Screening Plate Preparation and Compound Addition
384 well screening plates (Greiner) were coated with hESC-
qualified Matrigel (BD Biosciences) for one hour prior to addition
of hESCs. Each aliquot of Matrigel was diluted in Dulbecco’s
Modified Eagle Medium (DMEM)/F:12 (Life Technologies) as
described in the product insert. 30 ml diluted Matrigel was added
to each well of the screening plates using a Multidrop 384
equipped with a plate stacker (Thermo LabSystems). Plates were
then incubated one hour at room temperature. After incubation,
Matrigel was aspirated using an ELx 405 plate washer (Bio-Tek
Instruments). 30 ml per well of CM was then added using a
Multidrop 384. Screening compounds were then added using a
Biomek FX (Beckman Coulter) in 0.5 ml DMSO for a final
concentration of 10 mM. 20 ml per well of resuspended hESCs was
added to prepared screening plates using a Multidrop 384 for a
final assay volume of 50 ml. After addition of cells, screening plates
were incubated 2 days at 37uC. In parallel, an aliquot of cells were
taken and plated onto 6 well plates at each run to confirm viability
of cells at the start of the run. Libraries screened include the
Diversity, Targeted, Synergy, and Emerald sets from Asinex, the
Chembridge DiverSet, Microsource and Enamine libraries,
Biomol enzyme inhibitor and bioactive lipid libraries, and a
collection of off patent FDA-approved drugs collected at the
UCLA MSSR.
Labeling of Surviving hESCs and Data Acquisition from
Screening Plates
Three different methods were tested to quantify viable hESCs at
the end of the screening assay. In all cases, data were acquired
using an Acumen microplate cytometer (TTP Labtech). For
quantification of GFP signal from the OCT4-GFP reporter,
culture medium was aspirated and replaced with Dulbecco’s
phosphate buffered saline (dPBS, Life Technologies), after which
plates were immediately transferred to the Acumen system. For
propidium iodide staining of cells, medium was aspirated and
replaced with 50 ml per well 1 mg/ml propidium iodide (Life
Technologies) in dPBS with 0.1% Nonidet P-40 (Fluka) to
permeabilize cells. Cells were incubated 15 minutes at room
temperature prior to data acquisition on the Acumen system. To
use Calcein AM (eBioscience) to selectively label live cells, Calcein
AM was diluted from 2 mM DMSO stock in dPBS to a
concentration of 262.5 nM immediately prior to use. 20 ml per
well of this solution was added to screening plates without
removing culture medium. Plates were allowed to incubate 30
minutes at room temperature before data acquisition was
performed on the Acumen system. To improve throughput,
screening plates were stacked in a Twister plate handler robot
(Zymark) integrated with the Acumen instrument. Data acquisi-
tion and analysis was performed using the Acumen Explorer
software (TTP Labtech).
Screening Approach and Analysis
Primary screens were performed to identify small molecules that
increased the number of surviving hESCs 2 days after plating.
Data were normalized on a per plate basis and results for each
compound tested were expressed as a Z score, representing the
number of standard deviations from the population mean for each
plate. Compounds were identified as hits based on a sufficiently
high Z score (described in each assay) and retested in the primary
screening assay. Compounds that were confirmed to improve
hESC survival in the primary screening assay were then tested in a
OCT4 immunostaining assay to confirm that the increased
number of surviving cells remained pluripotent. Any compounds
that were confirmed to improve hESC in this secondary assay
would next need to be tested in tertiary assays to characterize
effects of the test compound on hESC proliferation, self-renewal,
and differentiation as well as the mechanism of action of the pro-
survival compound.
Chemical Screening in Human Embryonic Stem Cells
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Alkaline Phosphatase Assay
To test the effects of selected compounds on hESC survival of
H1 OCT4-GFP or H9 hESCs were dissociated and plated on
Matrigel coated 6 well plates in conditioned medium at an
equivalent density per cm2 to the 384 well screening assays. After 2
days in culture the cells were fixed in 4% formaldehyde (from
paraformaldehyde, Electron Microscopy Sciences). Alkaline phos-
phatase positive pluripotent cells were then stained by incubation
in 0.01% Naphthol AS-MX phosphate (Sigma) containing 1 mg/
ml Fast Red TR Salt (Sigma) for 30 minutes.
Immunofluorescence Analysis of hESCs
hESCs were washed with dPBS and fixed with 4% formalde-
hyde at room temperature for 30 minutes. hESCs were then
washed with dPBS, permeabilized in.1% Triton and blocked in
10% goat serum. Primary antibody (OCT4 used at 1:100 dilution,
Santa Cruz Biotechnology) was added in 1% goat serum overnight
at 4 degrees (384 well plates). hESCs were washed with dPBS and
FITC-conjugated secondary antibody (Thermo Scientific Pierce,
used at 1:500) was added for 1–2 hours at room temperature in the
dark. To visualize nuclei, Hoechst 33342 (Molecular Probes) was
added (1:1000) in dPBS.
Results
A Shorter Incubation Period can be used to Identify
Improved Survival in Dissociated hESCs
Because hESCs undergo apoptosis rapidly following dissociation
[19,20], we sought to identify the shortest end point at which we
could detect significant improvement in hESC survival due to
small molecule treatment. In our previous work, we were able to
identify small molecules improving hESC survival after 4 days in
the screening assay [11,18]. We observed that the magnitude of
enhancement in survival after treatment with 10 mM HA-1077
increased from day 1 to day 2 post-plating, but remained the same
from day 2 to day 4 post-plating (Figure 1). We also found that
aspirating the culture medium, and presumably debris from
apoptotic cells, increased the detectable fold-change in survival
after treatment with HA-1077. In addition, we were able to plate
dissociated hESCs in MEM-conditioned medium on Matrigel
coated plates in place of the MEF co-culture system used
previously.
H1 OCT4-GFP hESCs Exhibit Dim Fluorescence in the
High Content Assay Resulting in Additional Background
and Nonspecific Fluorescence
After optimizing the high throughput assay with regard to
culture conditions and duration we began to screen libraries of
unknown compounds (See Table S1 for complete OCT4-GFP
screen results). As compounds were identified in the Acumen
screen as improving the number of GFP positive objects identified
(Figure 2 A-C), we noted that the increased GFP signal did not
correspond to a visible improvement in surviving cells after visual
inspection under a light microscope. Wells with varying numbers
of GFP-positive objects detected were examined manually under
brightfield illumination and there was no noticeable correlation
between GFP signal and the number of surviving hESCs. While
positive control wells contained large highly compact hESC
colonies, small molecule-treated wells displaying increased GFP-
positive objects contained few surviving hESCs and large numbers
of dead cells and aggregated debris. Four selected compounds that
were identified as potential enhancers of hESC survival were
retested in the 384-well high throughput format as well as with an
alkaline phosphatase secondary assay to identify pluripotent cells.
Of the four compounds tested out of 18860 compounds screened,
only HA-1077 successfully improved survival of dissociated hESCs
(Figure 2 D-F,H).
Using a DNA Stain, Propidium Iodide, Presents an
Alternative Readout for Detecting Survival of Dissociated
hESCs in a High Throughput Assay
We hypothesized that nonspecific GFP signal in the OCT4-
GFP screening assay described above could be due to autofluo-
rescence of cellular debris or the screening compounds tested.
Because the Acumen microplate cytometer system does not
require a focal plane for imaging, it has a higher sensitivity to
background fluorescence that may not appear when using an
image-based readout. Because the OCT4-GFP cells have dim
GFP fluorescence even when OCT4 is highly expressed, even low
nonspecific fluorescence could be mistaken for GFP signal. To
overcome this nonspecific signal we tested the DNA stain
propidium iodide in our hESC screening assay. Because
propidium iodide is membrane impermeant, it was added to
plates in a solution of 0.1% Nonidet P-40 detergent in dPBS. Used
in a solution that would permeabilize cells, the propidium iodide
was selected to stain DNA in hESCs that had survived and
adhered to the tissue culture plate rather than serving as a direct
test of viability. After noting that the number of objects stained
with propidium iodide after 2 days was often similar between wells
with and without ROCK inhibitor, we hypothesized that plating
cells at a lower density would improve the detectable difference
between positive (HA-1077 treated) and negative (DMSO vehicle)
controls. We found that plating 2000 hESCs per well detected the
largest increase in survival over control due to HA-1077 treatment
(Figure 3). 17177 compounds that did not overlap with the OCT4-
GFP screen were tested in the survival assay with propidium iodide
readout (see Table S2 for complete results).
Selective Labeling of Viable Cells Provides a More
Specific Readout to Assess hESC Survival in High
Throughput Assays
While propidium iodide emits a more intense fluorescence than
the EGFP in the OCT4-EGFP reporter cell line, it is unable to
Figure 1. The greatest improvement in hESC survival due to
treatment with HA-1077 is seen after two days. H1 OCT4-GFP
hESCs were plated at 5000 cells/well on Matrigel in MEF-conditioned
medium treated with 0.1% DMSO (red) or 10 mM HA-1077 (blue).
Colored bars represent average number of GFP-positive objects
identified 6SD. Values over bars represent fold increase in objects
after treatment with HA-1077 relative to DMSO control. Statistical
significance of HA-1077 treatment was determined using analysis of
variance (ANOVA, ***: p,0.001).
doi:10.1371/journal.pone.0054948.g001
Chemical Screening in Human Embryonic Stem Cells
PLOS ONE | www.plosone.org 3 January 2013 | Volume 8 | Issue 1 | e54948
distinguish live and dead cells when used on permeabilized cells.
Though the culture medium was replaced with propidium iodide
in dPBS for staining, dead cells and debris that remained attached
to the well surface were also stained with propidium iodide,
leading to false positive results in high throughput assays screening
17177 compounds. To better distinguish surviving hESCs from
dead cells and debris we used Calcein AM, a dye that fluoresces
only after being taken up by viable cells and is retained within the
cell once in its fluorescent state. As with the propidium iodide
staining protocol, we tested multiple plating densities to determine
the number of cells that resulted in the greatest improvement in
positive control wells relative to untreated wells. We identified
1500 cells/well as the plating density that resulted in the greatest
improvement in survival due to HA-1077 treatment (Figure 4). We
then used a plating density of 1500 cells per well and a readout
using Calcein AM viability dye after two days to assess hESC
survival for screening the available small molecules in the UCLA
MSSR.
Evaluation of Primary Screening Data Identifies the Small
Molecule HA-1077 as a Regulator of hESC Survival
Our complete screen tested 85586 small molecules with 85503
unique structures for their effects on hESC survival (Figure 5,
Tables S3 and S4). For our initial analysis we chose to use the raw
number of Calcein AM positive objects per well, to avoid
introducing any bias due to selective filtering of results. We chose
the 320 compounds with the highest Z score (Z $4.58) for repeat
in the screening assay to confirm their effects on hESC survival.
Included in this set of 320 was the ROCK inhibitor HA-1077.
After repeating the primary Calcein screening assay with these
320 compounds, only two compounds produced an improvement
in Calcein positive objects greater than three standard deviations
from the plate mean (Figure 6A). To reconfirm the effects of these
Figure 2. Small molecules identified in the OCT4-GFP screening assay were not confirmed in secondary assays. Three treatments are
compared to assess changes in survival of dissociated hESCs: 0.1% DMSO (negative control; A,D), 10 mM HA-1077 (positive control; B,E), and 10 mM
AST 5588603 (representative of small molecules identified in OCT4-GFP screening assay; C,F). A-C: Readout from the Acumen microplate cytometer.
The wells treated with HA-1077 and AST 5588603 had similar numbers of GFP positive objects (quantified in G). D-F: Alkaline phosphatase staining of
cells treated as described. Pluripotent cells are stained with a red color. Wells treated with HA-1077 (E) contain significantly more pluripotent cells
than cells treated with DMSO or any other candidate compounds. G: Quantification of GFP signal detected in (A-C). H: Quantification of alkaline
phosphatase staining in (D-F) by calculating what percent of the well area stained positive for alkaline phosphatase. Data shown as mean 6SD, ***:
p,0.001.
doi:10.1371/journal.pone.0054948.g002
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compounds on hESC survival we also tested the set of 320
compounds using our previous OCT4 immunostaining assay [11].
Only treatment with HA-1077 resulted in an improvement in the
number of OCT4 positive cells (Figure 6B).
Applying Constraints to the Object Identification
Algorithm Improves the Ability to Distinguish Surviving
hESCs from Background Signal
Using an unbiased object identification algorithm we identified
ROCK as a key target for improving hESC survival. To identify
additional potential hits improving hESC survival, we explored
various filters that can be applied to specify when a fluorescent
signal is classified as an object by the Acumen Explorer software.
Parameters that were tested as potential filters include object
dimensions (length & width), perimeter, and mean fluorescence
intensity. We chose two object filter sets to characterize: one less
stringent set that required fluorescent objects to have a perimeter
$50 mm and area $125 mm2 to be counted and a more stringent
set that required only an object perimeter $100 mm. These
filtering strategies are referred to as area filtering and perimeter
filtering respectively and can be used to distinguish pro-survival
molecules such as the HA-1077 from molecules that were initially
identified as hits but that did not display any pro-survival effects in
follow-up testing such as T6140247 (Figure 7). While the two
compounds register a similar number of objects without filtering,
application of Area or Perimeter filtering more severely reduces
the number of objects identified in the T6140247 well, consistent
with the compound having no effect on the survival of dissociated
hESCs. Because using the more stringent perimeter filter resulted
in the highest average Z’ factor, representing the best separation of
positive and negative controls, we used this filtering parameter to
identify a second set of compounds with potential to improve
hESC survival.
Rescreening of Putative Hits from Revised Object
Identification Strategy Confirms a ROCK Inhibitor as a
Pro-survival Molecule in hESCs
After reanalyzing the 85586 compounds tested using our
perimeter-filtered object identification strategy, we observed 392
compounds with a Z score $3 and a Z’ factor $0.25. A set of 50
compounds was identified by selecting the compounds with the
largest Z scores ($3.55) for perimeter-filtered objects after limiting
the search to plates with a Z’ factor of at least 0.25 and compounds
that had not been previously identified as hits in our initial
evaluation of the primary data (Figure 6). These compounds were
then rescreened in the primary Calcein based assay (Figure 8). All
compounds but one fell below the Z score cutoff of 3 standard
deviations from the mean that we set as a minimum requirement
for positive hits. The only compound that produced a significant
(greater than 3 SD) improvement in hESC survival was the
ROCK inhibitor HA-1077.
Discussion
In this work, we set out to optimize our high content screening
assay to effectively screen larger libraries of small molecules than
the ,1600 tested in our first screening platform [11,18]. Several
aspects of the original high content assay setup and readouts were
problematic in scaling up the assay, and are addressed in our
optimized high throughput assay. Our first optimization was to
switch from the previously published culture system of plating
dissociated hESCs on MEFs to plating the cells on Matrigel coated
plates in medium that had been conditioned overnight on MEFs.
This optimization removed the presence of additional cell types in
the screen, reducing the complexity of the screen. This was
particularly helpful as we shifted the readout for the screen away
from OCT4 positive cells to simply viable cells. A second change
made to the assay was shortening the duration from 4 days to 2.
We found that there was no difference in the ability of our assay to
distinguish between positive and negative controls at 2, 3, or 4
days after plating (Figure 1) so we chose to use the shortest assay
possible while still maintaining the dynamic range of the assay.
While it is difficult to decouple survival and proliferation in an
endpoint assay, using a shorter assay places more emphasis on
initial survival of dissociated hESCs rather than proliferation after
attachment. A shorter assay also reduces the likelihood of hESCs
differentiating during the course of the assay. Characterization of
hits in tertiary assays would be used to more closely examine
Figure 3. Lower hESC plating density results in greater
observed changes in survival using propidium iodide. H1
OCT4-GFP hESCs were plated at the densities shown and treated with
10 mM HA-1077 (blue) or 0.1% DMSO (red). Colored bars represent
average number of PI-positive objects identified 6SD. Values over bars
represent fold increase in objects after treatment with HA-1077 relative
to DMSO control. Statistical significance of HA-1077 treatment was
determined using analysis of variance (ANOVA, ***: p,0.001).
doi:10.1371/journal.pone.0054948.g003
Figure 4. Altered hESC plating density improves the ability to
detect changes in survival using Calcein AM. H1 OCT4-GFP hESCs
were plated at the densities shown and treated with 10 mM HA-1077
(blue) or 0.1% DMSO (red) as a negative control. After 2 days viable cells
were quantified. Colored bars represent average number of Calcein-
stained objects identified 6SD. Values over bars represent fold increase
in objects after treatment with HA-1077 relative to DMSO control.
Statistical significance of HA-1077 treatment was determined using
analysis of variance (ANOVA, ***: p,0.001).
doi:10.1371/journal.pone.0054948.g004
Chemical Screening in Human Embryonic Stem Cells
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changes in proliferation, self-renewal, and differentiation. Focusing
our search on small molecules that improve the number of
surviving hESCs in a shorter time frame improves the likelihood of
finding small molecules affecting survival rather than self-renewal
or proliferation.
Perhaps the largest change from the original high content assay
is in the readout for surviving cells. While the original high content
assay uses immunostaining for the pluripotency marker OCT4 as
the readout for surviving hESCs, this readout is impractical for
screening larger libraries due to both the reagent costs and the
time and labor required to fix and stain hundreds of assay plates
for immunofluorescence. Our first proposed readout was to
measure OCT4 levels with a knock-in hESC line with EGFP
driven by the OCT4 promoter [21]. However we found that the
EGFP reporter was not sufficiently bright due to the fluorescent
reporter itself, and as a result our screening assay was unable to
sufficiently distinguish surviving hESCs from background signal
from autofluorescing dead cells or fluorescent compounds
(Figure 2). We next reasoned that a DNA-binding dye, propidium
iodide, would limit our fluorescent signal to only cells (Figure 3).
While the use of a non-specific DNA dye in place of an OCT4-
dependent readout makes it impractical to verify the stemness of
surviving cells, we were able to show that secondary assays could
easily be used to assess whether novel small molecules were
altering the self-renewal of the dissociated hESCs (Figures 2, 6).
However, when testing the use of propidium iodide as a readout in
our screening assay, we observed that hESCs that did not survive
would often stick to the Matrigel coating the bottom of the well
and would yield a positive signal mimicking viable cells. During
assay development we were able to identify increased survival in
groups of wells treated with positive control compounds, however
in primary screening we observed well to well variability in the
degree to which debris and dead cells were removed by washing,
leading to many false positives where increased PI signal did not
correlate with increased hESC survival. To address this we chose a
dye that is only fluorescent when internalized by live cells. Calcein
AM is the acetomethoxy derivative of the fluorescein-like dye
Calcein. Calcein AM is nonfluorescent and cell-permeable until
the acetomethoxy group is cleaved by intracellular esterases, at
which point the dye becomes brightly fluorescent and is retained
within the live cell. In the end we chose to use Calcein AM for our
readout of surviving cells due to its bright signal and specificity to
surviving cells. In the course of testing these readouts we found
that plating dissociated hESCs at a lower density resulted in a
larger dynamic range between positive and negative controls
(Figure 4). Based on this analysis, we chose a plating density of
1500 cells per well for our complete screen.
After completing our screen of the available libraries at the
UCLA MSSR (85586 compounds spanning 10 libraries) we then
identified potential hits that appeared to improve the survival of
dissociated hESCs. Although the software we used for data
acquisition, Acumen Explorer, allows for limiting the fluorescent
object identification according to various physical characteristics of
the fluorescent objects, we chose to use the unfiltered object
identification scheme to avoid potential biasing of our results. After
normalizing results between plates, we chose the 320 compounds
with the highest Z scores to assemble a cherry-picked plate to
confirm the activity of these compounds in hESCs (Figure 5). To
our surprise, the majority of the compounds we identified (318 of
320) had no effect on the number of Calcein positive objects in a
repeat of the primary screening assay (Figure 6A). As an
alternative assay we tested the cherry-picked 320 compounds
with the same OCT4 staining readout as our previous work [11].
Although we found two compounds that gave a high signal in the
Calcein assay (HA-1077 and T6140247) only one of them
improved the survival of dissociated hESCs (Figure 6B).
Figure 5. A Calcein based high throughput screen identifies potential regulators of hESC survival. Each blue point represents one of the
85586 small molecules tested. The black bar represents the cutoff (Z score $4.58) used to select a set of 320 compounds for follow up testing. The
ROCK inhibitor HA-1077 is circled in red (Z score: 5.34).
doi:10.1371/journal.pone.0054948.g005
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In comparing the data acquired for HA-1077 and T6140247 we
noticed that although both wells had a similar number of
fluorescent objects, the objects in the T6140247 were mostly
small punctate objects. In contrast, the objects in the HA-1077
well tended to be larger and better resembled growing hESCs. We
then used these two compounds as test cases to develop a set of
filtering parameters that excluded small points of fluorescence that
were coming from a source other than surviving hESCs. While the
number of objects detected decreased even in the HA-1077
(positive control) well, the decrease was much sharper in the well
Figure 6. Secondary assays confirmed the pro-survival effects of the ROCK inhibitor HA-1077 on OCT4 positive hESCs. A: 320
candidate small molecules were rescreened in identical conditions to the primary assay. 2 small molecules circled in red, HA-1077 and T6140247,
resulted in a significant (Z score $3 SD) improvement in viable Calcein positive objects. B: As a secondary assay, the 320 candidate molecules were
screened at 1500 cells per well. After two days, cells were stained with the pluripotency marker OCT4 and counterstained with Hoechst 33342, in
place of Calcein staining. The compounds identified in (A) are again circled. T6140247 is found clustered with other experimental samples (black) and
negative control wells (red), while HA-1077 is found clustered with positive control wells treated with 10 mM HA-1077 (blue).
doi:10.1371/journal.pone.0054948.g006
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without increased numbers of hESCs (T6140247), suggesting that
the correct object identification filters would help distinguish
Calcein-stained hESCs from other sources of fluorescence
(Figure 7). In addition to reducing the background signal from
the small punctate non-cell objects, utilizing the perimeter filtering
method improved the average Z’ factor of the assay from 0.236 to
0.488. The Z’ factor measures the distance between the positive
and negative controls, with the most effective screening assays
having a Z’ factor between 0.5 and 1.0 [22]. The assay Z’ factor
using perimeter filtering is close to the Z’ factor of 0.5 observed in
our previous screening assay, and suggests that the use of object
identification filters will be important in optimizing future cell-
based screens. Using the perimeter filtering method we selected
the 50 compounds with the highest Z scores for cherry-picking to a
new plate for retesting. After repeating our Calcein-based assay on
these 50 compounds, we found that only the known ROCK
inhibitor HA-1077 improved hESC survival by at least three
standard deviations versus control treated wells (Figure 8).
Interestingly, HA-1077 was also the only compound to result in
a similar Z score in both the primary screen and the rescreening
assay (5.29 and 4.63, respectively), while most compounds saw a
decrease of 3–5 SDs when rescreened. However, we also found 6
compounds that resulted in a moderate improvement in hESC
survival and could be investigated further in the future (Table S5).
Additional evaluation of compounds with Z scores less than 3 may
provide a method to identify small molecules with more modest
effects on hESC survival that may be useful at a higher
concentration or in combination with known ROCK inhibitors
to promote hESC survival.
This work was initiated as a method to identify novel targets
regulating the survival of dissociated hESCs beyond the known
target ROCK. Although reports describing the mechanism by
which ROCK is hyperactivated in hESCs after dissociation
leading to apoptosis have identified other potential targets for
regulating hESC survival [19,20], other published screening assays
have identified only small molecule inhibitors of ROCK as
improving hESC survival [15,16,17]. As in this work we also
identified the ROCK inhibitor, HA-1077, as the target with the
greatest improvement in hESC survival, we are confident that our
assay is capable of identifying small molecules that improve hESC
Figure 7. A perimeter-based object identification scheme results in the most robust detection of surviving hESCs. Three methods for
quantifying Calcein staining of hESCs were compared: Unfiltered imposed no constraints on the object identification, while Area filtering requires
fluorescent objects to have a perimeter $50 mm and area $125 mm2 to be counted and Perimeter filtering requires objects to have a perimeter
$100 mm. Images compare the two compounds highlighted in Figure 4.6: HA-1077 (left) and T6140247 (right). For each category, objects identified
are highlighted in white and quantified to the right of each image along with the percentage of the Unfiltered object count.
doi:10.1371/journal.pone.0054948.g007
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survival to a degree similar to known pro-survival compounds.
Further optimization of the assay could enlarge the distance
between the positive and negative controls and could be used to
search for novel targets that produce a more moderate improve-
ment in hESC survival relative to that seen using known ROCK
inhibitors.
The work demonstrates the feasibility of a high throughput,
high content screen assessing survival of dissociated hESCs.
Because ROCK inhibitors have been identified as the sole
enhancers of hESC survival by multiple groups [15,16,17], it
seems likely that any novel pathway promoting hESC survival has
a more modest effect than that seen with ROCK inhibition in the
current screening format. In the future, this assay could be
performed in the presence of a ROCK inhibitor in order to screen
for molecules that could be used in combination to further
improve hESC survival in a fashion similar to our previous work in
which we performed screens in the presence of ROCK inhibition
as a method of identifying molecules that inhibit hESC survival
[11].
In place of chemical libraries, cDNA or RNAi libraries could
also be screened using a similar approach of quantifying viable
cells after dissociation and replating. Screens using cDNA or
RNAi libraries also have the benefit of well-defined and specific
targets, compared to small molecules that frequently effect
multiple targets at varying efficacies [23]. In summary, we have
developed a high content screening assay to measure survival of
dissociated hESCs that can be easily scaled up in order to test large
libraries (85586 small molecules tested here). In this work, we
confirmed the role of ROCK inhbition in improving survival and
identified 6 more potential targets to follow up in future studies for
use in combination with ROCK inhibitors. In addition, future
applications for this optimized assay include continued screening
of chemical libraries for novel regulators of hESC survival and
screening of cDNA or RNAi libraries to shed light on additional
players important for regulating survival.
Supporting Information
Table S1 Normalized Z scores for OCT4-GFP based hESC
survival screen.
(XLS)
Table S2 Normalized Z scores for propidium iodide based
hESC survival screen.
(XLS)
Table S3 Normalized Z scores for Calcein AM based hESC
survival screen (unfiltered results).
(XLS)
Table S4 Normalized Z scores for Calcein AM based hESC
survival screen (perimeter filtered results).
(XLS)
Table S5 Normalized Z score results of rescreening in perimeter
filtered screen.
(XLS)
Acknowledgments
We would like to thank several individuals including Jong Lee, Winnie
Hwong, and Robert Damoiseaux at the Molecular Screening Shared
Resource (MSSR) for assistance with setting up the screening platform and
hit characterization. The authors would like to think Kellan Gregory at
Collaborative Drug Discovery for assistance with analyzing screening data.
Author Contributions
Conceived and designed the experiments: ADP SPS. Performed the
experiments: SPS. Analyzed the data: ADP SPS. Contributed reagents/
materials/analysis tools: ADP. Wrote the paper: SPS ADP.
References
1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, et al.
(1998) Embryonic stem cell lines derived from human blastocysts. Science 282:
1145–1147.
2. Baker DEC, Harrison NJ, Maltby E, Smith K, Moore HD, et al. (2007)
Adaptation to culture of human embryonic stem cells and oncogenesis in vivo.
Nat Biotechnol 25: 207–215.
3. Osafune K, Caron L, Borowiak M, Martinez RJ, Fitz-Gerald CS, et al. (2008)
Marked differences in differentiation propensity among human embryonic stem
cell lines. Nat Biotech 26: 313–315.
4. Pyle AD, Lock LF, Donovan PJ (2006) Neurotrophins mediate human
embryonic stem cell survival. Nat Biotechnol 24: 344–350.
5. Edel MJ, Menchon C, Menendez S, Consiglio A, Raya A, et al. (2010) Rem2
GTPase maintains survival of human embryonic stem cells as well as enhancing
reprogramming by regulating p53 and cyclin D1. Genes Dev 24: 561–573.
6. Ardehali R, Inlay MA, Ali SR, Tang C, Drukker M, et al. (2011) Overexpression
of BCL2 enhances survival of human embryonic stem cells during stress and
obviates the requirement for serum factors. Proceedings of the National
Academy of Sciences 108: 3282–3287.
7. Bai H, Chen K, Gao Y-X, Arzigian M, Xie Y-L, et al. (2012) Bcl-xL enhances
single-cell survival and expansion of human embryonic stem cells without
affecting self-renewal. Stem Cell Research 8: 26–37.
8. Inniss K, Moore H (2006) Mediation of apoptosis and proliferation of human
embryonic stem cells by sphingosine-1-phosphate. Stem Cells Dev 15: 789–796.
9. Wong RCB, Tellis I, Jamshidi P, Pera M, Pe´bay A (2007) Anti-apoptotic effect of
sphingosine-1-phosphate and platelet-derived growth factor in human embry-
onic stem cells. Stem Cells Dev 16: 989–1001.
10. Watanabe K, Ueno M, Kamiya D, Nishiyama A, Matsumura M, et al. (2007) A
ROCK inhibitor permits survival of dissociated human embryonic stem cells.
Nat Biotechnol 25: 681–686.
11. Damoiseaux R, Sherman SP, Alva JA, Peterson C, Pyle AD (2009) Integrated
chemical genomics reveals modifiers of survival in human embryonic stem cells.
Stem Cells 27: 533–542.
12. Barbaric I, Jones M, Buchner K, Baker D, Andrews PW, et al. (2011) Pinacidil
enhances survival of cryopreserved human embryonic stem cells. Cryobiology
63: 298–305.
13. Claassen DA, Desler MM, Rizzino A (2009) ROCK inhibition enhances the
recovery and growth of cryopreserved human embryonic stem cells and human
induced pluripotent stem cells. Molecular Reproduction and Development 76:
722–732.
14. Li X, Krawetz R, Liu S, Meng G, Rancourt DE (2009) ROCK inhibitor
improves survival of cryopreserved serum/feeder-free single human embryonic
stem cells. Human Reproduction 24: 580–589.
Figure 8. Rescreening of candidate molecules after perimeter
based filtering identifies targets with pro-survival effects on
hESCs. The top 50 compounds according to Z score of perimeter
filtered objects, all with a Z’ factor .0.25, were repeated in the Calcein
screening assay. Points represent the Z score, or number of standard
deviations from the mean, of each sample in the original screening run
(blue) or in the reconfirmation experiment (red).
doi:10.1371/journal.pone.0054948.g008
Chemical Screening in Human Embryonic Stem Cells
PLOS ONE | www.plosone.org 9 January 2013 | Volume 8 | Issue 1 | e54948
15. Xu Y, Zhu X, Hahm HS, Wei W, Hao E, et al. (2010) Revealing a core signaling
regulatory mechanism for pluripotent stem cell survival and self-renewal by small
molecules. Proc Natl Acad Sci USA.
16. Andrews PD, Becroft M, Aspegren A, Gilmour J, James MJ, et al. (2010) High-
content screening of feeder-free human embryonic stem cells to identify pro-
survival small molecules. Biochem J 432: 21–33.
17. Barbaric I, Gokhale PJ, Jones M, Glen A, Baker D, et al. (2010) Novel regulators
of stem cell fates identified by a multivariate phenotype screen of small
compounds on human embryonic stem cell colonies. Stem Cell Res 5: 104–119.
18. Sherman SP, Alva JA, Thakore-Shah K, Pyle AD (2011) Human pluripotent
stem cells: the development of high-content screening strategies. Methods Mol
Biol 767: 283–295.
19. Chen G, Hou Z, Gulbranson DR, Thomson JA (2010) Actin-Myosin
Contractility Is Responsible for the Reduced Viability of Dissociated Human
Embryonic Stem Cells. Cell Stem Cell 7: 240–248.
20. Ohgushi M, Matsumura M, Eiraku M, Murakami K, Aramaki T, et al. (2010)
Molecular Pathway and Cell State Responsible for Dissociation-Induced
Apoptosis in Human Pluripotent Stem Cells. Cell Stem Cell 7: 225–239.
21. Kamei K-I, Guo S, Yu ZTF, Takahashi H, Gschweng E, et al. (2009) An
integrated microfluidic culture device for quantitative analysis of human
embryonic stem cells. Lab Chip 9: 555–563.
22. Zhang J, Chung T, Oldenburg K (1999) A Simple Statistical Parameter for Use
in Evaluation and Validation of High Throughput Screening Assays. J Biomol
Screen 4: 67–73.
23. Davies SP, Reddy H, Caivano M, Cohen P (2000) Specificity and mechanism of
action of some commonly used protein kinase inhibitors. Biochem J 351: 95–
105.
Chemical Screening in Human Embryonic Stem Cells
PLOS ONE | www.plosone.org 10 January 2013 | Volume 8 | Issue 1 | e54948
